You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 23, 2025

Details for Patent: 6,956,026


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,956,026
Title: Use of exendins for the reduction of food intake
Abstract:Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that affect satiety. The methods are useful for treating conditions or disorders, including obesity, Type II diabetes, eating disorders, and insulin-resistance syndrome. The methods are also useful for lowering the plasma glucose level, lowering the plasma lipid level, reducing the cardiac risk, reducing the appetite, and reducing the weight of subjects. Pharmaceutical compositions for use in the methods of the invention are also disclosed.
Inventor(s): Beeley; Nigel Robert Arnold (Solana Beach, CA), Bhavsar; Sunil (San Diego, CA)
Assignee: Amylin Pharmaceuticals, Inc. (San Diego, CA)
Application Number:09/003,869
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,956,026
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,956,026

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to understand its significance, protection, and potential implications. This article will provide a detailed analysis of United States Patent 6,956,026, focusing on its claims, the technology it covers, and its position within the patent landscape.

Patent Overview

United States Patent 6,956,026 is a patent that has been granted for a specific invention. To begin, it is essential to identify the key elements of the patent, including the title, inventors, assignees, and the date of issuance.

Claims Analysis

Independent and Dependent Claims

The claims section of a patent is the most critical part, as it defines the scope of protection granted to the inventor. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details[3].

  • Independent Claims: These claims outline the core aspects of the invention and are typically broader in scope.
  • Dependent Claims: These claims are narrower and specify additional features or limitations of the invention.

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This process is crucial for understanding what the patent protects and what it does not. It often involves analyzing the claim language, the specification, and the prosecution history of the patent[2].

Scope of Protection

The scope of protection for a patent is determined by its claims. Here are some key aspects to consider:

Technology Covered

Identify the specific technology or innovation that the patent protects. This could include methods, products, or systems related to the invention.

Novelty and Non-Obviousness

Ensure that the claims meet the criteria of novelty and non-obviousness as required by patent law. This involves comparing the invention to prior art and determining whether it would have been obvious to a person of ordinary skill in the field[2].

Patent Landscape Analysis

Competitor Patents

Analyze the patents held by competitors in the same field to identify gaps, overlaps, and potential areas of conflict. This can be done using patent analytics tools that categorize patents by claims and scope concepts[3].

Global Dossier

Utilize the Global Dossier service provided by the USPTO to access file histories of related applications from participating IP Offices. This helps in understanding the global patent family and identifying potential issues or opportunities[4].

Claim Coverage Matrix

A Claim Coverage Matrix is a valuable tool for understanding which patents and claims are actively protecting your intellectual property. It categorizes patents by claims and overarching scope concepts, making it easier to filter, search, and analyze large numbers of patent claims concurrently[3].

Claim Charts and Technical Review

Interactive Claim Charts

Use ClaimScape® software or similar tools to generate interactive claim charts. These charts help technical experts review patent coverage and determine whether a particular scope concept is applicable to a target product or method. This method is quick and accurate, highlighting gaps in current coverage and future design opportunities[3].

Technical Expert Review

Involve engineers, scientists, and management in the review process to ensure that the patent claims align with the company's current and future technological directions. This helps in identifying high-value claims, medium-value claims indicating potential future directions, and low-value claims that may not be worth maintaining[3].

Regulatory and Legal Considerations

Patent Term Extensions

Understand the potential for patent term extensions, such as those provided under 35 U.S.C. § 156 for patents subject to regulatory review periods. This can extend the life of the patent, but it is subject to specific limitations and requirements[1].

Obviousness-Type Double Patenting

Be aware of the doctrine of obviousness-type double patenting, which can invalidate claims if they are not patentably distinct from earlier-filed or earlier-issued patents. This doctrine ensures that an inventor does not receive multiple patents for the same invention[2].

Litigation and Infringement

Infringement Analysis

Conduct thorough infringement analyses to determine if other entities are infringing on the patent. This involves comparing the claims of the patent with the products or methods of potential infringers[5].

Litigation History

Review any litigation history related to the patent or similar patents in the field. This can provide insights into how courts have interpreted similar claims and the potential strengths and weaknesses of the patent in legal disputes[2].

Key Takeaways

  • Claims Are Key: The claims section of a patent defines its scope of protection.
  • Patent Landscape: Analyzing the broader patent landscape helps in identifying gaps, overlaps, and opportunities.
  • Regulatory Considerations: Understand the potential for patent term extensions and the limitations imposed by regulatory review periods.
  • Technical Review: Involve technical experts to ensure alignment with current and future technological directions.
  • Litigation Awareness: Be aware of potential infringement and the litigation history of similar patents.

FAQs

Q: What is the primary purpose of the claims section in a patent? A: The primary purpose of the claims section is to define the scope of protection granted to the inventor, outlining what the patent covers and what it does not.

Q: How does a Claim Coverage Matrix help in patent analysis? A: A Claim Coverage Matrix helps by categorizing patents by claims and overarching scope concepts, making it easier to filter, search, and analyze large numbers of patent claims concurrently.

Q: What is the doctrine of obviousness-type double patenting? A: The doctrine of obviousness-type double patenting is a legal principle that prevents an inventor from receiving multiple patents for the same invention by ensuring that claims are patentably distinct from earlier-filed or earlier-issued patents.

Q: How can the Global Dossier service be useful in patent analysis? A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users understand the global patent family and identify potential issues or opportunities.

Q: Why is it important to involve technical experts in reviewing patent claims? A: Involving technical experts ensures that the patent claims align with the company's current and future technological directions, helping to identify high-value claims and potential gaps in coverage.

Sources

  1. FDA-2017-E-5040-0001: IN THE UNITED STATES PATENT AND TRADEMARK OFFICE.
  2. ALLERGAN USA, INC. v. MSN LABORATORIES PRIVATE LTD.: United States Court of Appeals for the Federal Circuit.
  3. Patent Analytics: Intellectual Property Law, Schwegman.
  4. Search for patents - USPTO: United States Patent and Trademark Office.
  5. Case 1:15-cv-01139-UNA Document 1 Filed 12/09/15: Insight.RPXCorp.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,956,026

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,956,026

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 0996459 ⤷  Try for Free CA 2007 00034 Denmark ⤷  Try for Free
European Patent Office 0996459 ⤷  Try for Free 91342 Luxembourg ⤷  Try for Free
European Patent Office 0996459 ⤷  Try for Free C00996459/01 Switzerland ⤷  Try for Free
European Patent Office 0996459 ⤷  Try for Free 0790031-9 Sweden ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.